JNTU Hyderabad | Current Status And Future Prospects in Pharmacy Education and Research -Towards Industry Application

 

DOWNLOAD HERE 

Drug Patent Expirations for the week of October 27, 2013

Tradename	Applicant	Generic Name	Patent No.
MACUGEN	Valeant Pharms Llc	pegaptanib sodium	6,113,906
MACUGEN	Valeant Pharms Llc	pegaptanib sodium	5,919,455
BACTROBAN	Glaxosmithkline	mupirocin calcium	5,569,672
YAZ	Bayer Hlthcare	drospirenone; ethinyl estradiol	5,569,652
YASMIN	Bayer Hlthcare	drospirenone; ethinyl estradiol	5,569,652
SAMSCA	Otsuka America Pharm	tolvaptan	5,258,510
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

DRUGS BANNED IN INDIA

Drug Patent Expirations for the week of October 20, 2013

Tradename	Applicant	Generic Name	Patent No.
LOTEMAX	Pharmos	loteprednol etabonate	5,540,930
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

CSIR – INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY | WALK-IN-INTERVIEW 30th October 2013 | Eligibility B-Pharmacy with GPAT |

CSIR – INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY

Hyderabad-500 007

Notification No.11/2013

WALK-IN-INTERVIEW

CSIR-IICT is conducting Walk-in-Interview

 for the following positions on a purely temporary basis for  various projects as detailed below at IICT Hyderabad

S.No	Projects	Position	Requirements	Qualification	Experience	Date of Interview
1	CSC0301 ACT & CSC0302 ADD	Project Fellow	4	M.Sc. (Organic Chemistry) WITH CSIR- UGC NET qualified or B.Pharm with GPAT	Desirable:M.Pharm/MS Pharm with knowledge in areas of drug delivery systems / analytical method development	30th October 2013